✦ LIBER ✦

Preservation of the Immunogenicity of Dry-powder Influenza H5N1 Whole Inactivated Virus Vaccine at Elevated Storage Temperatures

✍ Scribed by Felix Geeraedts; Vinay Saluja; Wouter ter Veer; Jean-Pierre Amorij; Henderik W. Frijlink; Jan Wilschut; Wouter L. J. Hinrichs; Anke Huckriede

Book ID: 111767632
Publisher: American Association of Pharmaceutical Scientists
Year: 2010
Tongue: English
Weight: 306 KB
Volume: 12
Category: Article
ISSN: 1550-7416
DOI: 10.1208/s12248-010-9179-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Production of H5N1 (NIBRG-14) inactivate

Production of H5N1 (NIBRG-14) inactivated whole virus and split virion influenza vaccines and analysis of immunogenicity in mice using different adjuvant formulations

✍ Cosue Miyaki; Wagner Quintilio; Eliane N. Miyaji; Viviane F. Botosso; Flavia S. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 385 KB

Safety and immunogenicity of inactivated

Safety and immunogenicity of inactivated, Vero cell culture-derived whole virus influenza A/H5N1 vaccine given alone or with aluminum hydroxide adjuvant in healthy adults

✍ Wendy A. Keitel; Cornelia L. Dekker; ChrisAnna Mink; James D. Campbell; Kathryn 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 338 KB

Evaluation of the cellular immune respon

Evaluation of the cellular immune responses induced by a non-adjuvanted inactivated whole virus A/H5N1/VN/1203 pandemic influenza vaccine in humans

✍ Brian A. Crowe; Peter Brühl; Marijan Gerencer; Michael G. Schwendinger; Andreas 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 417 KB

Phase I and II randomised trials of the

Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adults

✍ Terry M. Nolan; Peter C. Richmond; Maryanne V. Skeljo; Georgina Pearce; Gunter H 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 591 KB